[Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998; 437(3): 207-210.10.1016/S0014-5793(98)01217-4]Search in Google Scholar
[Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41(2): 277-281.10.1002/ana.410410222]Search in Google Scholar
[Oliva R, Tolosa E, Ezquerra M, Molinuevo JL, Valldeoriola F, Burguera J, Calopa M, Villa M, Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 1998; 55(8): 1122-1124.10.1001/archneur.55.8.1122]Search in Google Scholar
[Bennett P, Bonifati V, Bonuccelli U, Colosimo C, de Mari M, Fabbrini G, Marconi R, Meco, G, Nicholl DJ, Stocchi F, Vanacore N, Vieregge P, Williams AC. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. Neurology 1998; 51(4): 982-985.10.1212/WNL.51.4.982]Search in Google Scholar
[Morris HR, Janssen JC, Bandmann O, Daniel SR, Rossor, MN, Lees AJ, Wood NW. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 1999; 66(5): 665-667.10.1136/jnnp.66.5.665]Search in Google Scholar
[Higgins JJ, Golbe LI, de Biase A, Jankovic J, Factor SA, Adler RL. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy. Neurology 2000; 55(9): 1364-1367.10.1212/WNL.55.9.1364]Search in Google Scholar
[Hoenicka J, Perez M, Perez-Tur J, Barabash A, Godoy M, Vidal L, Astarloa R, Avila J, Nygaard T, de Yebenes JG. The tau gene A0 allele and progressive supranuclear palsy. Neurology 1999; 1(2): 1219-1225.10.1212/WNL.53.6.1219]Search in Google Scholar
[Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8(4): 711-715.10.1093/hmg/8.4.711]Search in Google Scholar
[Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, Ozansoy M, Hardy J, Hutton M, Wood NW, Lees AJ, Revesz T, Lantos P, Rossor MN. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 2001; 58(11): 1813-1816.10.1001/archneur.58.11.1813]Search in Google Scholar
[Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999; 46(2): 243-248.10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-L]Search in Google Scholar
[Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56(12): 1702-1706.10.1212/WNL.56.12.1702]Search in Google Scholar
[Conrad C, Vianna C, Freeman M, Davies P. Saitohin, a novel putative gene in the tau locus. Proc Natl Acad Sci USA 2002; 99(11): 7751-7756.10.1073/pnas.112194599]Search in Google Scholar
[de Silva R, Hope A, Pittman A, Weale ME, Morris HR, Wood NW, Lees AJ. Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 2003; 61(3): 407-409.10.1212/01.WNL.0000073140.25533.90]Search in Google Scholar
[Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. Neurosci Lett 2001; 299(1-2): 156-158.10.1016/S0304-3940(00)01785-7]Search in Google Scholar
[Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, Lees AJ, Lantos PL, Hutton M. Analysis of tau haplotypes in Pick's disease. Neurology 2002; 59(3): 443-445.10.1212/WNL.59.3.443]Search in Google Scholar
[Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994; 369(6480): 488-491.10.1038/369488a0]Search in Google Scholar
[Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 2001; 114(6): 1179-1187.10.1242/jcs.114.6.1179]Search in Google Scholar
[Haltiwanger RS, Busby S, Grove K, Li S, Mason D, Medina L, Moloney D, Philipsberg G, Scartozzi R. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?. Biochem Biophys Res Commun 1997; 231(2): 237-242.10.1006/bbrc.1997.6110]Search in Google Scholar
[Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins. J Biol Chem 1997; 272(14): 9308-9315.10.1074/jbc.272.14.9308]Search in Google Scholar
[Kamemura K, Hart GW. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol 2003; 73: 107-136.10.1016/S0079-6603(03)01004-3]Search in Google Scholar
[Dong DL, Xu ZS, Hart GW, Cleveland DW. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J Biol Chem 1996; 271(34): 20845-20852.10.1074/jbc.271.34.20845]Search in Google Scholar
[Lovestone S, Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997; 78(2): 309-324.]Search in Google Scholar
[Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg L, Trojanowski JQ. Detection of phosphorylated Ser262 in fetal tau, adult tau and paired helical filament tau. J Biol Chem 1995; 270(32): 18917-18922.10.1074/jbc.270.32.18917]Search in Google Scholar
[Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 1997; 409(1): 57-62.10.1016/S0014-5793(97)00483-3]Search in Google Scholar
[Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 2002; 51(4): 525-530.10.1002/ana.10163]Search in Google Scholar
[Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 1999; 443(2): 93-96.10.1016/S0014-5793(98)01696-2]Search in Google Scholar
[Jiang Z, Cote J, Kwon JM, Goate AM, Wu JY. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol Cell Biol 2000; 20(11): 4036-4048.10.1128/MCB.20.11.4036-4048.20008577410805746]Search in Google Scholar
[Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, Wood N, Khan MN, Cipolotti L, Fox NC, Rossor MN. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology 2002; 58(8): 1161-1168.10.1212/WNL.58.8.116111971081]Search in Google Scholar
[Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 2001; 56(11 Suppl 4): S1-S25.10.1212/WNL.56.suppl_4.S2111402146]Search in Google Scholar
[Poorkaj P, Grossman M, Steinbart E, Payami H, Sdaovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001; 58(3): 383-387.10.1001/archneur.58.3.38311255441]Search in Google Scholar
[Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, Pickering-Brown S, Duff K, Hutton M. 5' Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999; 274(21): 15134-15143.10.1074/jbc.274.21.1513410329720]Search in Google Scholar
[Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95(13): 7737-7741.10.1073/pnas.95.13.7737]Search in Google Scholar
[Varani L, Hasegawa M, Spillantini MG, Smith MJ, Murrell JR, Ghetti B, Klug A, Goedert M, Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999; 96(14): 8229-8234.10.1073/pnas.96.14.8229]Search in Google Scholar
[Spillantini MG, van Swieten JC, Goedert M,. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000; 2(4): 193-205.10.1007/s100489900084]Search in Google Scholar
[Yen S, Easson C, Nacharaju P, Hutton M, Yen SH. FTDP-17 tau mutations decrease the susceptibility of tau to calpain 1 digestion. FEBS Lett 1999; 461(1-2): 91-95.10.1016/S0014-5793(99)01427-1]Search in Google Scholar
[Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003; 424(6950): 805-808.10.1038/nature0189112917692]Search in Google Scholar
[Molinuevo JL, Valldeoriola F, Alegret M, Oliva R, Tolosa E. Progressive supranuclear palsy: earlier age of onset in patients with the ô protein A0/A0 genotype. J Neurol 2000; 247(3): 206-208.10.1007/s00415005056410787116]Search in Google Scholar
[Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, Morris JGL, Fulham MJ, Schofield PR. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Brain 2000; 123(5): 880-893.10.1093/brain/123.5.88010775534]Search in Google Scholar
[Rojo A, Pernaute RS, Fontan A, Ruiz PG, Honnorat J, Lynch T, Chin S, Gonzalo I, Rabano A, Martinez A, Daniel S, Pramsteller P, Morris H, Wood N, Lees A, Tabernero C, Nyggard T, Jackson AC, Hanson A, de Yébenes JG. Clinical genetics of familial progressive supranuclear palsy. Brain 1999; 122(7): 1233-1245.10.1093/brain/122.7.123310388790]Search in Google Scholar
[Higgins JJ, Rima L, Adler BA, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology 1999; 2(7): 1421-1424.10.1212/WNL.53.7.142110534245]Search in Google Scholar
[Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998; 8(2): 355-365.10.1111/j.1750-3639.1998.tb00159.x80983609546292]Search in Google Scholar
[Spillantini MG, Bird TD, Ghetti B. Fronto-temporal dementia and parkinsonism linked to chromosome 17: a new group of taupathies. Brain Pathol 1998; 8(2): 387-402.10.1111/j.1750-3639.1998.tb00162.x]Search in Google Scholar
[Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9(4): 681-693.10.1111/j.1750-3639.1999.tb00550.x]Search in Google Scholar
[Virginia M, Lee Y, Trojanowski JQ. Neurodegenerative tauopathies: human disease and transgenic mouse models. Neuron 1999; 24(3): 507-510.10.1016/S0896-6273(00)81106-X]Search in Google Scholar
[Heutink P. Untangling tau-related dementia. Hum Mol Genet 2000; 9(6): 979-986.10.1093/hmg/9.6.97910767321]Search in Google Scholar
[Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995; 242(2): 99-104.10.1007/BF008878247707098]Search in Google Scholar
[Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Arch Neurol 1995; 52(4): 379-391.10.1001/archneur.1995.005402800650207710374]Search in Google Scholar
[Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG, Pavan WJ. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997; 277(5323): 232-235.10.1126/science.277.5323.2329211850]Search in Google Scholar
[Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 1995; 118(1): 119-129.10.1093/brain/118.1.1197894998]Search in Google Scholar
[Auer IA, Schmidt ML, Lee VMY, Curry B, Suzuki K, Shin RW, Pentchev PG, Carstea ED, Trojanowski JQ. Paired helical filament tau (PHF-tau) in Niemann-Pick tytpe C disease is similar to PHF-tau in Alzheimer's disease. Acta Neuropathol 1995; 90(6): 547-551.10.1007/BF003185668615074]Search in Google Scholar
[Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005; 1739(2-3): 179-197.10.1016/j.bbadis.2004.06.02015615637]Search in Google Scholar
[Andreadis A, Wagner BK, Broderick JA, Kosik KS. A tau promoter region without neuronal specificity. J Neurochem 1996; 66(6): 2257-2263.10.1046/j.1471-4159.1996.66062257.x]Search in Google Scholar
[Heicklen-Klein A, Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2. J Neurochem 2000; 75(4): 1408-1418.10.1046/j.1471-4159.2000.0751408.x]Search in Google Scholar
[Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992; 31(43): 10626-10633.10.1021/bi00158a027]Search in Google Scholar
[Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 2004; 24(4): 277-295.10.1002/humu.20086]Search in Google Scholar
[Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human micro-tubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3(4): 519-526.10.1016/0896-6273(89)90210-9]Search in Google Scholar
[Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8(2): 393-399.10.1002/j.1460-2075.1989.tb03390.x]Search in Google Scholar
[Brandt R, Leger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1995; 131(5): 1327-1340.10.1083/jcb.131.5.1327]Search in Google Scholar
[Hirokawa N, Shiomura Y, Okabe S. Tau proteins: the molecular structure and mode of binding on microtubules. J Cell Biol 1988; 107(4): 1449-1459.10.1083/jcb.107.4.1449]Search in Google Scholar
[Buée L, Bussiére T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev, 2000; 33(1): 95-130.10.1016/S0165-0173(00)00019-9]Search in Google Scholar
[Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005; 1739(2-3): 198-210.10.1016/j.bbadis.2004.09.00815615638]Search in Google Scholar
[Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256(5054): 184-185.10.1126/science.1566067]Search in Google Scholar
[Buée-Scherrer V, Buée L, Leveugle D, Perl P, Vermesch P, Hof PR, Delacourte A. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Ann Neurol 1997; 42(3): 356-359.10.1002/ana.410420312]Search in Google Scholar
[Tolnay M, Probst A. The neuropathological spectrum of neurodegenerative tauopathies. Int Union Biochem Mol Biol Life 2003; 55(6): 299-305.10.1080/1521654032000114348]Search in Google Scholar
[Albers DS, Augood SJ. New insights into progressive supranuclear palsy. Trends Neurosci 2001; 24(6): 347-352.10.1016/S0166-2236(00)01794-X]Search in Google Scholar